Predictive Nomograms for Clinical Outcomes in Hepatitis B-Related Cirrhosis Patients Receiving Antiviral Therapy

被引:4
作者
Cheng, Ran [1 ]
Xu, Jinghang [1 ]
Tan, Ning [1 ]
Luo, Hao [1 ]
Pan, Jiali [1 ]
Xu, Xiaoyuan [1 ]
机构
[1] Peking Univ First Hosp, Dept Infect Dis, Beijing 100034, Peoples R China
关键词
antiviral therapy; liver-related events; hepatocellular carcinoma; liver-related mortality; albumin-bilirubin; REDUCES HEPATOCELLULAR-CARCINOMA; SIMPLE NONINVASIVE INDEX; SIGNIFICANT FIBROSIS; SCORING SYSTEM; RISK; PROGNOSIS;
D O I
10.2147/IDR.S316026
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: Many scores have been constructed to predict liver-related events in chronic hepatitis B, while most of them are based on baseline clinical parameters. The objective of this study was to develop nomograms based on on-treatment improvement in established scores to predict clinical outcomes in patients with hepatitis B virus (HBV)-related cirrhosis who are receiving antiviral therapy. Methods: The Cox proportional hazards regression model was used. Nomograms were constructed for the prediction of liver-related events, hepatocellular carcinoma (HCC), and liver-related mortality risk during long-term antiviral therapy. Results: A total of 277 treatment-naive patients with HBV-associated cirrhosis were enrolled from January 2010 to December 2013. After a median follow-up of 63.3 months, 95 patients developed liver-related events, including 59 patients with liver-related death. Multivariate Cox analysis showed that the albumin-bilirubin score at year 1 was an independent predictor of liver-related events, liver-related mortality, and HCC. Age, decompensation, and delayed virological remission were independent factors for liver-related mortality. Age was also a risk factor for liver-related events. The concordance index values of event nomogram, mortality-nomogram, and HCC-nomogram were 0.742 (95% confidence interval [CI], 0.691 similar to 0.793), 0.799 (95% CI, 0.748 similar to 0.850), and 0.613 (95% CI, 0.540 similar to 0.686), respectively. The calibration plots showed an agreement between the predicted and observed incidences, which indicates good calibration of the model of event-nomogram and mortality-nomogram. Conclusion: The nomograms achieved an optimal preoperative prediction of liver-related events, mortality, and HCC development in patients with HBV-related cirrhosis receiving antiviral therapy. These findings may help to identify high-risk patients for further optimal surveillance and intervention strategies.
引用
收藏
页码:2707 / 2719
页数:13
相关论文
共 32 条
[1]   Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B [J].
Chang, Ting-Tsung ;
Liaw, Yun-Fan ;
Wu, Shun-Sheng ;
Schiff, Eugene ;
Han, Kwang-Hyub ;
Lai, Ching-Lung ;
Safadi, Rifaat ;
Lee, Samuel S. ;
Halota, Waldemar ;
Goodman, Zachary ;
Chi, Yun-Chan ;
Zhang, Hui ;
Hindes, Robert ;
Iloeje, Uchenna ;
Beebe, Suzanne ;
Kreter, Bruce .
HEPATOLOGY, 2010, 52 (03) :886-893
[2]   Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level [J].
Chen, CJ ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Lu, SN ;
Huang, GT ;
Iloeje, UH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01) :65-73
[3]   Usefulness of albumin-bilirubin grade for evaluation of long-term prognosis for hepatitis B-related cirrhosis [J].
Chen, R. -C. ;
Cai, Y. -J. ;
Wu, J. -M. ;
Wang, X. -D. ;
Song, M. ;
Wang, Y. -Q. ;
Zheng, M. -H. ;
Chen, Y. -P. ;
Lin, Z. ;
Shi, K. Q. .
JOURNAL OF VIRAL HEPATITIS, 2017, 24 (03) :238-245
[4]   A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir [J].
Chiang, Hung-Hsien ;
Lee, Chuan-Mo ;
Hu, Tsung-Hui ;
Hung, Chao-Hung ;
Wang, Jing-Houng ;
Lu, Sheng-Nan ;
Lai, Hsueh-Chou ;
Su, Wen-Pang ;
Lin, Chia-Hsin ;
Peng, Cheng-Yuan ;
Chen, Chien-Hung .
LIVER INTERNATIONAL, 2018, 38 (11) :1997-2005
[5]   COMPARING THE AREAS UNDER 2 OR MORE CORRELATED RECEIVER OPERATING CHARACTERISTIC CURVES - A NONPARAMETRIC APPROACH [J].
DELONG, ER ;
DELONG, DM ;
CLARKEPEARSON, DI .
BIOMETRICS, 1988, 44 (03) :837-845
[6]   EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis [J].
Angeli P. ;
Bernardi M. ;
Villanueva C. ;
Francoz C. ;
Mookerjee R.P. ;
Trebicka J. ;
Krag A. ;
Laleman W. ;
Gines P. .
JOURNAL OF HEPATOLOGY, 2018, 69 (02) :406-460
[7]   Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection [J].
Hosaka, Tetsuya ;
Suzuki, Fumitaka ;
Kobayashi, Masahiro ;
Seko, Yuya ;
Kawamura, Yusuke ;
Sezaki, Hitomi ;
Akuta, Norio ;
Suzuki, Yoshiyuki ;
Saitoh, Satoshi ;
Arase, Yasuji ;
Ikeda, Kenji ;
Kobayashi, Mariko ;
Kumada, Hiromitsu .
HEPATOLOGY, 2013, 58 (01) :98-107
[8]   Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B [J].
Hsu, Yao-Chun ;
Yip, Terry Cheuk-Fung ;
Ho, Hsiu J. ;
Wong, Vincent Wai-Sun ;
Huang, Yen-Tsung ;
El-Serag, Hashem B. ;
Lee, Teng-Yu ;
Wu, Ming-Shiang ;
Lin, Jaw-Town ;
Wong, Grace Lai-Hung ;
Wu, Chun-Ying .
JOURNAL OF HEPATOLOGY, 2018, 69 (02) :278-285
[9]   Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach-The ALBI Grade [J].
Johnson, Philip J. ;
Berhane, Sarah ;
Kagebayashi, Chiaki ;
Satomura, Shinji ;
Teng, Mabel ;
Reeves, Helen L. ;
O'Beirne, James ;
Fox, Richard ;
Skowronska, Anna ;
Palmer, Daniel ;
Yeo, Winnie ;
Mo, Frankie ;
Lai, Paul ;
Inarrairaegui, Mercedes ;
Chan, Stephen L. ;
Sangro, Bruno ;
Miksad, Rebecca ;
Tada, Toshifumi ;
Kumada, Takashi ;
Toyoda, Hidenori .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) :550-U45
[10]   Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents [J].
Kim, Chang Ha ;
Um, Soon Ho ;
Seo, Yeon Seok ;
Jung, Jin Yong ;
Kim, Jin Dong ;
Yim, Hyung Joon ;
Keum, Bora ;
Kim, Yong Sik ;
Jeen, Yoon Tae ;
Lee, Hong Sik ;
Chun, Hoon Jai ;
Kim, Chang Duck ;
Ryu, Ho Sang .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (10) :1589-1595